Andrew Grace, HRC 2019 – Year in Review: Cardiac Implantable Devices – Implantable Cardioverter Defibrillators/Subcutaneous Implantable Cardioverter Defibrillators
Dr Andrew Grace (Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK) spoke to us at the 2019 Heart Rhythm Congress (HRC) in Birmingham, UK, and gave us a quick rundown of his Year in Review presentation on implantable cardioverter defibrillators (ICDs) and subcutaneous ICDs.
Speaker’s Disclosures: Andrew Grace has nothing to declare in relation to this video interview.
1. Year in Review: Cardiac Implantable Devices – Implantable Cardioverter Defibrillators/Subcutaneous Implantable Cardioverter Defibrillators (0:09)
2. How did the debate go on non-contact mapping? (1:18)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the Heart Rhythm Congress (HRC) 2019 in Birmingham, UK, October 2019 in partnership with Arrhythmia Alliance.
Share this Video
Related Videos In Devices
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Andrew Krahn: Heart Rhythm 2023 & HRX 2023 – The latest Innovations in arrhythmia care and technology
Dr Andrew Krahn, President, Heart Rhythm Society (HRS), discusses the upcoming Heart Rhythm 2023 meeting (May 19-21, 2023, New Orleans, LA, USA), and the HRX 2023 conference (September 21-23, 2023, in Seattle, WA, USA) hosted by the Heart Rhythm Society (HRS), a non-profit organization dedicated to improving the care of patients with heart rhythm disorders […]
Steven Messe, TCT 2022: Sentinel® cerebral protection system efficacy in reducing all stroke/disabling stroke, the PROTECTED-TAVR trial (a neurologist’s perspective)
The PROTECTED-TAVR trial studied the efficacy of using an embolic protection device (Sentinel® cerebral protection system) during transcatheter aortic valve replacement in reducing the incidence of stroke/disabling stroke. In this touchCARDIO interview, we speak with Dr Steven Messe (University of Pennsylvania, Philadelphia, PA, USA) to give a Neurologist’s perspective on the findings of the PROTECTED-TAVR […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!